TEG-001

N/A

Report date: 2024/11/25 11:39:06

Base Information

Drug NameTEG-001
Drug Alias NameTEG-001TEG-001 (αβ T cells expressing the high affinity Vγ9Vδ2 TCR clone 5)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT-cell receptor modulators
TargetsT-cell receptor
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGadeta BV
China Registration ClassN/A

Develop Information

Active CompaniesGadeta BV
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A